Showing results (461-470 of 479) with videos related to

Sort By:
Pageof 48
Annals of Internal Medicine|April 25, 2022
International Validation of the Canadian Syncope Risk Score : A Cohort StudyTobias Zimmermann, Jeanne du Fay de Lavallaz, Thomas Nestelberger, et al.
Pediatric Blood & Cancer|January 21, 2026
Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune CytopeniaZsuzsanna Gaál, Cristina Meehan, Melis Yilmaz, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|July 14, 2020
The Clinical and Genetic Spectrum of 82 Patients With RAG Deficiency Including a c.256_257delAA Founder Variant in Slavic CountriesSvetlana O Sharapova, Małgorzata Skomska-Pawliszak, Yulia A Rodina, et al.
The Journal of Experimental Medicine|May 2, 2025
Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiencyRiccardo Castagnoli, Francesca Pala, Poorani Subramanian, et al.
The Journal of Allergy and Clinical Immunology. Global|July 23, 2025
Factors associated with and kinetics of anti-IFN-α autoantibodies in RAG1/2 deficiencyChen Wang, David Evan Potts, Bijun Sun, et al.
The Journal of Clinical Investigation|October 13, 2015
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiencyJolan E Walter, Lindsey B Rosen, Krisztian Csomos, et al.
Frontiers in Immunology|March 11, 2020
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) SurveyAlice Y Chan, Jennifer W Leiding, Xuerong Liu, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2026
Targeted deep sequencing identifies mosaicism in patients with immune dysregulationElizabeth G Schmitz, Alexander J Paul, Rajarshi Ghosh, et al.
Pageof 48